Willis Investment Counsel’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-76,320
| Closed | -$8.11M | – | 112 |
|
2019
Q1 | $8.11M | Sell |
76,320
-361,120
| -83% | -$38.4M | 0.56% | 64 |
|
2018
Q4 | $20.9M | Sell |
437,440
-5,040
| -1% | -$241K | 1.55% | 17 |
|
2018
Q3 | $22.2M | Sell |
442,480
-34,320
| -7% | -$1.72M | 1.53% | 18 |
|
2018
Q2 | $24M | Sell |
476,800
-13,920
| -3% | -$701K | 1.77% | 8 |
|
2018
Q1 | $24M | Buy |
490,720
+71,600
| +17% | +$3.5M | 1.85% | 9 |
|
2017
Q4 | $18.6M | Buy |
419,120
+6,960
| +2% | +$309K | 1.31% | 27 |
|
2017
Q3 | $20.9M | Buy |
412,160
+12,800
| +3% | +$650K | 1.51% | 18 |
|
2017
Q2 | $21.5M | Hold |
399,360
| – | – | 1.63% | 9 |
|
2017
Q1 | $21M | Buy |
399,360
+8,160
| +2% | +$430K | 1.58% | 13 |
|
2016
Q4 | $18.8M | Buy |
391,200
+53,680
| +16% | +$2.58M | 1.41% | 25 |
|
2016
Q3 | $18.2M | Buy |
337,520
+10,800
| +3% | +$582K | 1.46% | 19 |
|
2016
Q2 | $17.7M | Buy |
326,720
+4,080
| +1% | +$221K | 1.51% | 15 |
|
2016
Q1 | $16.4M | Buy |
322,640
+20,000
| +7% | +$1.01M | 1.44% | 20 |
|
2015
Q4 | $15.3M | Hold |
302,640
| – | – | 1.39% | 21 |
|
2015
Q3 | $14.5M | Buy |
302,640
+24,960
| +9% | +$1.2M | 1.42% | 15 |
|
2015
Q2 | $14.5M | Buy |
277,680
+28,872
| +12% | +$1.5M | 1.37% | 18 |
|
2015
Q1 | $14.4M | Buy |
248,808
+33,760
| +16% | +$1.95M | 1.33% | 18 |
|
2014
Q4 | $11.5M | Sell |
215,048
-52,480
| -20% | -$2.8M | 1.08% | 32 |
|
2014
Q3 | $15.4M | Buy |
267,528
+29,040
| +12% | +$1.67M | 1.62% | 20 |
|
2014
Q2 | $15.9M | Buy |
238,488
+9,200
| +4% | +$615K | 1.56% | 20 |
|
2014
Q1 | $15.3M | Sell |
229,288
-1,680
| -0.7% | -$112K | 1.55% | 20 |
|
2013
Q4 | $15.4K | Buy |
230,968
+35,040
| +18% | +$2.34K | 0.72% | 21 |
|
2013
Q3 | $12.2M | Hold |
195,928
| – | – | 1.4% | 27 |
|
2013
Q2 | $12.2M | Buy |
+195,928
| New | +$12.2M | 1.4% | 27 |
|